Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201212075 Principal Investigator: Wagner-Johnston, Nina
Title: A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of GS 1101 (CAL-101) in Combination with Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Phase: III Disease Site: Lymphoid Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to provide more information about whether giving ofatumumab and GS 1101 together is effective and safe for treating people with CLL.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)